Real-world effectiveness of prophylactic tixagevimab-cilgavimab monoclonal antibodies on incidence and severity of COVID-19 infection in patients with cancer

被引：0
|
作者：
Naser, Maryam [1 ]
Bhardwaj, Prarthna V. [1 ]
Warriach, Fatima Zahid [1 ]
Jadoon, Yamna [1 ]
Gupta, Kush [1 ]
Rastegar, Vida [1 ]
Loke, Chandravathi [1 ]
Malleshappa, Sudeep Kumar Siddappa [1 ]
机构：
[1] Univ Massachusetts, Chan Med Sch Baystate, Springfield, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18843
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prophylactic effect of tixagevimab-cilgavimab on COVID-19 infection and death in Japanese patients with B cell lymphoma
    Tatetsu, Hiro
    Higuchi, Yusuke
    Shichijo, Takafumi
    Oda, Kazutaka
    Nakata, Hirotomo
    Yasunaga, Jun-Ichirou
    Nosaka, Kisato
    Matsuoka, Masao
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 118 (02) : 303 - 305
  • [2] Real-world clinical effectiveness of Tixagevimab/Cilgavimab and Regdanvimab monoclonal antibodies for COVID-19 treatment in Omicron variant-dominant period
    Fomina, Daria S.
    Lebedkina, Marina S.
    Iliukhina, Anna A.
    Kovyrshina, Anna V.
    Shelkov, Artem Y.
    Andreev, Sergey S.
    Chernov, Anton A.
    Dolzhikova, Inna V.
    Kruglova, Tatyana S.
    Andrenova, Gerelma V.
    Tukhvatulin, Amir I.
    Shcheblyakov, Dmitry V.
    Karaulov, Alexander V.
    Lysenko, Maryana A.
    Logunov, Denis Y.
    Gintsburg, Alexander L.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [3] REAL-WORLD EFFECTIVENESS AND SAFETY OF TIXAGEVIMAB-CILGAVIMAB: A TARGET TRIAL EMULATION STUDY
    Yan, V
    Yang, Y.
    Wan, E. Y. F.
    Yiu, H. H. E.
    Wong, I. C. K.
    Chan, E. W.
    VALUE IN HEALTH, 2023, 26 (12) : S221 - S221
  • [4] Real-World Effectiveness and Safety of Tixagevimab-Cilgavimab: A Target Trial Emulation Study
    Yan, Vincent Ka Chun
    Yang, Yu
    Wan, Eric Yuk Fai
    Lai, Francisco Tsz Tsun
    Chui, Celine Sze Ling
    Li, Xue
    Wong, Carlos King Ho
    Hung, Ivan Fan Ngai
    Lau, Chak Sing
    Wong, Ian Chi Kei
    Chan, Esther Wai Yin
    DRUG SAFETY, 2024, 47 (10) : 1025 - 1037
  • [5] The Prevention of COVID-19 in High-Risk Patients Using Tixagevimab-Cilgavimab (Evusheld): Real-World Experience at a Large Academic Center
    Al-Obaidi, Mohanad M.
    Gungor, Ahmet B.
    Kurtin, Sandra E.
    Mathias, Ann E.
    Tanriover, Bekir
    Zangeneh, Tirdad T.
    AMERICAN JOURNAL OF MEDICINE, 2023, 136 (01): : 96 - 99
  • [6] Tixagevimab-Cilgavimab for Breakthrough COVID-19 Prevention in Dialysis Patients: A Prospective Study
    Sritippayawan, Suchai
    Boongird, Sarinya
    Srithongkul, Thatsaphan
    Sethakarun, Sethanant
    Bruminhent, Jackrapong
    Kiertiburanakul, Sasisopin
    Nongnuch, Arkom
    Kitiyakara, Chagriya
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [7] Tixagevimab-cilgavimab for preventing breakthrough COVID-19 in dialysis patients: a prospective study
    Boongird, Sarinya
    Srithongkul, Thatsaphan
    Sethakarun, Sethanant
    Bruminhent, Jackrapong
    Kiertiburanakul, Sasisopin
    Nongnuch, Arkom
    Kitiyakara, Chagriya
    Sritippayawan, Suchai
    CLINICAL KIDNEY JOURNAL, 2024, 17 (11)
  • [8] Real-World Effectiveness of Tixagevimab and Cilgavimab (Evusheld) in Patients With Hematological Malignancies
    Ocon, Anthony J.
    Ocon, Kate E.
    Battaglia, Jennifer
    Low, Soon Khai
    Neupane, Niraj
    Saeed, Hasseen
    Jamshed, Saad
    Mustafa, S. Shahzad
    JOURNAL OF HEMATOLOGY, 2022, 11 (06) : 210 - 215
  • [9] Prophylaxis with tixagevimab/cilgavimab is associated with lower COVID-19 incidence and severity in patients with autoimmune diseases
    Thomas, Marion
    Masson, Maeva
    Bitoun, Samuel
    Hamroun, Sabrina
    Seror, Raphaele
    Dupuy, Henry
    Lazaro, Estibaliz
    Richez, Christophe
    Allanore, Yannick
    Avouac, Jerome
    RHEUMATOLOGY, 2024, 63 (06) : 1632 - 1638
  • [10] Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study
    Azuly, Hovav
    Shafat, Tali
    Grupel, Daniel
    Porges, Tzvika
    Abuhasira, Ran
    Belkin, Ana
    Deri, Ofir
    Oster, Yonatan
    Zahran, Shadi
    Horwitz, Ehud
    Horowitz, Netanel A.
    Khatib, Hazim
    Batista, Marjorie Vieira
    Cortez, Anita Cassoli
    Brosh-Nissimov, Tal
    Segman, Yafit
    Ishay, Linor
    Cohen, Regev
    Atamna, Alaa
    Spallone, Amy
    Chemaly, Roy F.
    Ramos, Juan Carlos
    Chowers, Michal
    Rogozin, Evgeny
    Oren, Noga Carmi
    Keske, Siran
    Barchad, Orit Wolfovitz
    Nesher, Lior
    INFECTIOUS DISEASES AND THERAPY, 2025, 14 (01) : 167 - 180
12345